380 related articles for article (PubMed ID: 14685853)
1. Non-alcoholic fatty liver disease: an emerging pathological spectrum.
Zafrani ES
Virchows Arch; 2004 Jan; 444(1):3-12. PubMed ID: 14685853
[TBL] [Abstract][Full Text] [Related]
2. Ectopic fat, insulin resistance and non-alcoholic fatty liver disease.
Byrne CD
Proc Nutr Soc; 2013 Nov; 72(4):412-9. PubMed ID: 23668723
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Farrell GC; Larter CZ
Hepatology; 2006 Feb; 43(2 Suppl 1):S99-S112. PubMed ID: 16447287
[TBL] [Abstract][Full Text] [Related]
4. [Non-alcoholic fatty liver disease--new view].
Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D; Schattenberg JM
J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():68-76. PubMed ID: 23855299
[TBL] [Abstract][Full Text] [Related]
7. [Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview].
Macías-Rodríguez RU; Torre A
Rev Invest Clin; 2009; 61(2):161-72. PubMed ID: 19637730
[TBL] [Abstract][Full Text] [Related]
8. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.
Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH
Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341
[TBL] [Abstract][Full Text] [Related]
9. The epidemiology of nonalcoholic fatty liver disease in adults.
Clark JM
J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic steatohepatitis.
Brunt EM
Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
[TBL] [Abstract][Full Text] [Related]
11. Microcirculatory disturbances and cellular changes during progression of hepatic steatosis to liver tumors.
Liebig M; Hassanzada A; Kämmerling M; Genz B; Vollmar B; Abshagen K
Exp Biol Med (Maywood); 2018 Jan; 243(1):1-12. PubMed ID: 29065724
[TBL] [Abstract][Full Text] [Related]
12. Recent concepts in non-alcoholic fatty liver disease.
Adams LA; Angulo P
Diabet Med; 2005 Sep; 22(9):1129-33. PubMed ID: 16108837
[TBL] [Abstract][Full Text] [Related]
13. The epidemiology, pathogenesis and histopathology of fatty liver disease.
Levene AP; Goldin RD
Histopathology; 2012 Aug; 61(2):141-52. PubMed ID: 22372457
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease.
Krawczyk M; Bonfrate L; Portincasa P
Best Pract Res Clin Gastroenterol; 2010 Oct; 24(5):695-708. PubMed ID: 20955971
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
16. The Natural Course of Non-Alcoholic Fatty Liver Disease.
Calzadilla Bertot L; Adams LA
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213358
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants.
Pais R; Lebray P; Rousseau G; Charlotte F; Esselma G; Savier E; Thabut D; Rudler M; Eyraud D; Vezinet C; Siksik JM; Vaillant JC; Hannoun L; Poynard T; Ratziu V
Clin Gastroenterol Hepatol; 2015 May; 13(5):992-9.e2. PubMed ID: 25459558
[TBL] [Abstract][Full Text] [Related]
18. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease.
Nobili V; Manco M; Ciampalini P; Diciommo V; Devito R; Piemonte F; Comparcola D; Guidi R; Marcellini M
Eur J Endocrinol; 2006 Nov; 155(5):735-43. PubMed ID: 17062890
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
20. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
